Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group.

Source:http://linkedlifedata.com/resource/pubmed/id/12566906

Download in:

View as

General Info

PMID
12566906